Location: Home
  • search
  • go
  • Relate News
  • 1/10/2023Viking Thera Sues Ascletis Bio of 'Ruse' to Raid Trade Secrets
  • 1/9/2023Fake Indian COVID-19 Medicines Flood China's Black Market
  • 1/9/2023Pfizer's Negotiation with China for NRDL Listing of Covid Drug Paxlovi...
  • 1/9/2023NMPA Announces Package Insert Revision of Ibandronate Sodium Inj and T...
  • 1/9/2023CDE Issues the List of Reference Formulations for GQCE Studies (63rd B...
  • 1/9/2023Shionogi to Diversify Sourcing of APIs and Raw Materials Away from Ch...
  • 1/9/2023Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...
  • 1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...
  • 1/6/2023Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)
  • 1/6/2023Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)
  • 1/6/2023Pfizer Reportedly in Talks with China over Paxlovid Generic
  • 1/6/2023CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...
  • 1/6/2023CDE Solicits Comments on Draft Implementation Proposal and Chinese Tra...
  • 1/6/2023CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11
  • 1/6/2023China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...
  • 1/6/2023Latest Cancer Drugmaker's IPO Mints China's Latest Billionaire
  • 1/6/2023Recent Executive Moves
  • 1/6/2023Drug R&D and Product Registration News Digest January 2023 (1)
  • 1/5/2023GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...
  • 1/5/2023CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...
  • 1/5/2023NMPA Holds National Drug Regulatory Conference in Beijing
  • 1/5/20232022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...
  • 1/5/2023Adcendo ApS Announces License Agreement with Duality Biologics on Next...
  • 1/5/2023Aurisco to Build Oligonucleotides Manufacturing Facility in China
  • 1/5/2023Shionogi Covid Drug Xocova May Get Chinese Approval in March
  • 1/5/202320 Promising New Drugs Anticipated To Be Approved in China 2023 (Pharm...
  • 1/5/2023FDA's Wang Yaning: Anti-Aβ Therapies Can Delay Progression of AD (Pha...
  • 1/4/2023Biocytogen and Hansoh Pharma Enter Antibody License Deal for China
  • 1/4/2023NHC and SATCM Announce Action Plan for the Overall Pain Management Tri...
  • 1/3/2023Fosun Pharma and Henlius Entered into an Exclusive License Agreement f...
  • Page:147/806 Total number of articles:24168: [First][<<] [145] [146] [147] [148] [149] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group